Recurrent group B stretococcus infection in an extremely premature infant: as a preterm neonate, infant and toddler

BMJ Case Rep. 2023 Jul 28;16(7):e255216. doi: 10.1136/bcr-2023-255216.

Abstract

We report five discrete episodes of group B streptococcus (GBS) bacteraemia in an extremely premature infant, extending into early childhood. The first four episodes occurred during infancy despite appropriate treatment. Breastmilk was positive for group B streptococcal 16S DNA by polymerase chain reaction. The fifth episode occurred at 17 months of age, shortly after stopping antimicrobial prophylaxis.Radiological investigations did not identify a focus for recurrence of GBS bacteraemia, and immunological investigations and targeted whole genome sequencing yielded only transient hypogammaglobulinaemia of infancy, which resolved.This case highlights invasive GBS infection as a cause of infant morbidity. Premature infants are at particular risk of invasive as well as recurrent disease. GBS is typically a sensitive organism and each episode of GBS in our patient was effectively treated with penicillin. The role of breastmilk in recurrent GBS is controversial; in this case infant and mother isolated identical GBS serotypes and were concurrently treated with rifampicin.

Keywords: Infectious diseases; Neonatal and paediatric intensive care; Neurology (drugs and medicines).

Publication types

  • Case Reports

MeSH terms

  • Bacteremia*
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Extremely Premature
  • Infant, Newborn
  • Milk, Human
  • Penicillins / therapeutic use
  • Pregnancy
  • Pregnancy Complications, Infectious* / drug therapy
  • Streptococcal Infections* / diagnosis
  • Streptococcal Infections* / drug therapy
  • Streptococcus agalactiae

Substances

  • Penicillins